Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis

키워드

참고문헌 (34)

1. Calandra T, "Macrophage migration inhibitory factor: a regulator of innate immunity", Nat Rev Immunol, 3, pp.791~800 (2003)[DOI]
2. Gregory JL, "Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2", J Immunol, 177, pp.8072~8079 (2006)[DOI]
3. Tillmann S, "Arrest functions of the MIF ligand", receptor axes in atherogenesis, 2013, pp.4, 115~
4. Santos LL, "Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis", Clin Chim Acta, 399, pp.1~7 (2013)
5. Morand EF, "MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis", Nat Rev Drug Discov, 5, pp.399~410 (2006)[DOI]
6. Baugh JA, "Macrophage migration inhibitory factor", Crit Care Med, 30, pp.S27~S35 (2002)[DOI]
7. Lolis E, "Macrophage migration inhibitory factor", Expert Opin Ther Targets, 7, pp.153~164 (2003)[DOI]
8. Leng L, "Macrophage migration inhibitory factor", Critical Care Med, 33, pp.S475~S477 (2005)[DOI]
9. Coban N, "Oxidative stress-mediated (sex-specific) loss of protection against type-2 diabetes by macrophage migration inhibitory factor (MIF)-173G", C polymorphism, 2015, pp.438, 1~6
10. Calandra T, "MIF as a glucocorticoid-induced modulator of cytokine production", Nature, 377, pp.68~71 (1995)[DOI]
11. Awandare GA, "MIF (macrophage migration inhibitory factor) promoter polymorphism and susceptibility to severe malarial anemia", J Infect Dis, 200, pp.629~637 (2009)[DOI]
12. Yende S, "The influence of macrophage migration inhibitory factor gene polymorphism on outcome from community-acquired pneumonia", FASEB J, 23, pp.2403~2411 (2009)[DOI]
13. Renner P, "A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease", FASEB J, 26, pp.907~916 (2012)[DOI]
14. Cooper AM, "The role of cytokines in the initiation, expansion,and control of cellular immunity to tuberculosis", Immunol Rev, 226, pp.191~204 (2008)[DOI]
15. Ameglio F, "Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis", Int J Tuberc Lung Dis, 9, pp.98~104 (2005)
16. Munk ME, "Functions of T-cell subsets and cytokines in mycobacterial infections", Eur Respir J, 20, pp.668~675 (1995)
17. Boom WH, "Human immunity to M. tuberculosis: T cell subsets and antigen processing", Tuberculosis, 83, pp.98~106 (2003)[DOI]
18. Denis M, "Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates", Cell Immunol, 132, pp.150~157 (1991)[DOI]
19. Gutierrez MG, "Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages", Cell, 119, pp.753~766 (2004)[DOI]
20. Jacobs M, "Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha -deficient mice", Clin Immunol, 94, pp.192~199 (2000)[DOI]
21. Van CR, "Innate immunity to Mycobacterium tuberculosis", Clin Microbiol Rev, 15, pp.294~309 (2002)[DOI]
22. White DA, "Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells", PloS One, 8, pp.e76206~ (2013)[DOI]
23. Llamas-Covarrubias MA, "Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis", Cytokine, 61, pp.759~765 (2013)[DOI]
24. Vassalli P, "The pathophysiology of tumor necrosis factors", Annu Rev Immunol, 10, pp.411~452 (1992)[DOI]
25. Pasparakis M, "Tumour necrosis factors in immune regulation: everything that's interesting is. . .new!", Cytokine Growth Factor Rev, 7, pp.223~229 (1996)[DOI]
26. Flynn JL, "Immunology of tuberculosis", Annu Rev Immunol, 19, pp.93~129 (2001)[DOI]
27. Berry MP, "An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis", Nature, 466, pp.973~977 (2010)[DOI]
28. Bean AG, "Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin", J Immunol, 162, pp.3504~3511 (1999)
29. Chakravarty SD, "Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs", Infect Immun, 76, pp.916~926 (2008)[DOI]
30. Roach DR, "Secreted lymphotoxin-<TEX>${\alpha}$<", TEX> is essential for the control of an intracellular bacterial infection, 2001, pp.193, 239~246
31. Botha T, "Reactivation of latent tuberculosis infection in TNF-deficient mice", J Immunol, 171, pp.3110~3118 (2003)[DOI]
32. Mohan VP, "Effects of tumor necrosis factor <TEX>${\alpha}$<", TEX> on host immune response in chronic persistent tuberculosis: possible role for limiting pathology, 2001, pp.69, 1847~1855
33. Smith SM, "Decreased IFN-gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients", Tuberculosis, 82, pp.7~13 (2002)[DOI]
34. Sharma S, "Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumor necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis", Immunol Cell Biol, 82, pp.377~382 (2004)[DOI]

관련 논문AI추천